Search Results - "Spoon, Dan"
-
1
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
Published in Blood (15-07-2001)“…This report of a phase 2 trial of thalidomide (THAL) (200 mg/d; 200 mg increment every 2 weeks to 800 mg) for 169 patients with advanced myeloma (MM) (abnormal…”
Get full text
Journal Article -
2
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
Published in Blood (15-06-2000)“…High-dose therapy (HDT) has increased complete remission (CR) rates and survival in multiple myeloma (MM). We now report on continuous CR (CCR) and associated…”
Get full text
Journal Article -
3
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
Published in Blood (15-06-2000)“…High-dose therapy (HDT) has increased complete remission (CR) rates and survival in multiple myeloma (MM). We now report on continuous CR (CCR) and associated…”
Get full text
Journal Article -
4
Predicting long‐term (≥ 5 years) event‐free survival in multiple myeloma patients following planned tandem autotransplants
Published in British journal of haematology (01-01-2002)“…Although outcome in multiple myeloma (MM) patients has improved significantly with the introduction of autotransplants (AT), the curability of this approach…”
Get full text
Journal Article -
5
Infection – an underappreciated cause of bone pain in multiple myeloma
Published in British journal of haematology (01-03-2003)“…Bone pain, especially back pain, is a common presenting feature of myeloma patients. We report three multiple myeloma patients with exacerbations of back pain…”
Get full text
Journal Article